KCK LTD.

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return -61% 8.2% 15.1%
Success rate 14% 68% 82%
Transactions
34 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
KCK LTD.'s trades of Neuropace Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-20 2025-02-20
US Neuropace Inc (NPCE)
S Sale
9,636 +40.7%
173.36
US$4,340,219 		9,636 +40.7% 173.36 US$4,340,219
2024-10-28 2024-10-25
US Neuropace Inc (NPCE)
PrS Proposed sale
17,890
89.48
US$3,610,587 		17,890 89.48 US$3,610,587
2024-10-28 2024-10-25
US Neuropace Inc (NPCE)
S Sale
59,363 -44.1%
460.10
US$2,526,362 		59,363 -44.1% 460.10 US$2,526,362
2024-10-28 2024-10-23
US Neuropace Inc (NPCE)
S Sale
147 -0.0%
6.02
US$885 		147 -0.0% 6.02 US$885
2024-10-24 2024-10-22
US Neuropace Inc (NPCE)
S Sale
4,082 -0.1%
6.09
US$24,853 		4,082 -0.1% 6.09 US$24,853
2024-10-22 2024-10-21
US Neuropace Inc (NPCE)
S Sale
3,720 -0.1%
6.10
US$22,679 		3,720 -0.1% 6.10 US$22,679
2024-10-22 2024-10-18
US Neuropace Inc (NPCE)
S Sale
4,878 -0.1%
6.29
US$30,692 		4,878 -0.1% 6.29 US$30,692
2024-10-18 2024-10-17
US Neuropace Inc (NPCE)
S Sale
3,294 -0.1%
6.28
US$20,686 		3,294 -0.1% 6.28 US$20,686
2024-10-18 2024-10-16
US Neuropace Inc (NPCE)
S Sale
6,900 -0.1%
6.57
US$45,336 		6,900 -0.1% 6.57 US$45,336
2024-10-18 2024-10-15
US Neuropace Inc (NPCE)
S Sale
4,017 -0.1%
6.50
US$26,098 		4,017 -0.1% 6.50 US$26,098
2024-10-18 2024-10-14
US Neuropace Inc (NPCE)
S Sale
4,031 -0.1%
6.54
US$26,360 		4,031 -0.1% 6.54 US$26,360
2024-10-18 2024-10-11
US Neuropace Inc (NPCE)
S Sale
2,572 -0.0%
6.35
US$16,320 		2,572 -0.0% 6.35 US$16,320
2024-10-18 2024-10-10
US Neuropace Inc (NPCE)
S Sale
2,504 -0.0%
6.12
US$15,317 		2,504 -0.0% 6.12 US$15,317
2024-10-18 2024-10-09
US Neuropace Inc (NPCE)
S Sale
3,123 -0.1%
6.10
US$19,065 		3,123 -0.1% 6.10 US$19,065
2024-10-18 2024-10-08
US Neuropace Inc (NPCE)
S Sale
6,000 -0.1%
6.43
US$38,552 		6,000 -0.1% 6.43 US$38,552
2024-10-18 2024-10-07
US Neuropace Inc (NPCE)
S Sale
4,910 -0.1%
6.66
US$32,687 		4,910 -0.1% 6.66 US$32,687
2024-10-18 2024-10-04
US Neuropace Inc (NPCE)
S Sale
5,757 -0.1%
6.92
US$39,830 		5,757 -0.1% 6.92 US$39,830
2024-10-18 2024-10-03
US Neuropace Inc (NPCE)
S Sale
3,318 -0.1%
6.97
US$23,115 		3,318 -0.1% 6.97 US$23,115
2024-10-03 2024-10-02
US Neuropace Inc (NPCE)
S Sale
3,843 -0.1%
6.87
US$26,401 		3,843 -0.1% 6.87 US$26,401
2024-10-03 2024-10-01
US Neuropace Inc (NPCE)
S Sale
4,882 -0.1%
6.77
US$33,051 		4,882 -0.1% 6.77 US$33,051
2024-10-03 2024-09-30
US Neuropace Inc (NPCE)
S Sale
4,749 -0.1%
6.73
US$31,961 		4,749 -0.1% 6.73 US$31,961
2024-10-03 2024-09-27
US Neuropace Inc (NPCE)
S Sale
5,059 -0.1%
6.63
US$33,541 		5,059 -0.1% 6.63 US$33,541
2024-10-03 2024-09-26
US Neuropace Inc (NPCE)
S Sale
5,821 -0.1%
6.62
US$38,535 		5,821 -0.1% 6.62 US$38,535
2024-10-03 2024-09-25
US Neuropace Inc (NPCE)
S Sale
5,858 -0.1%
6.60
US$38,663 		5,858 -0.1% 6.60 US$38,663
2024-10-03 2024-09-23
US Neuropace Inc (NPCE)
S Sale
282 -0.0%
7.54
US$2,126 		282 -0.0% 7.54 US$2,126
2024-10-03 2024-09-20
US Neuropace Inc (NPCE)
S Sale
765 -0.0%
7.50
US$5,738 		765 -0.0% 7.50 US$5,738
2024-10-03 2024-09-13
US Neuropace Inc (NPCE)
S Sale
1,993 -0.0%
7.59
US$15,127 		1,993 -0.0% 7.59 US$15,127
2024-10-03 2024-09-06
US Neuropace Inc (NPCE)
S Sale
11 -0.0%
7.50
US$82 		11 -0.0% 7.50 US$82
2024-10-03 2024-09-04
US Neuropace Inc (NPCE)
S Sale
14 -0.0%
7.50
US$105 		14 -0.0% 7.50 US$105
2024-10-03 2024-09-03
US Neuropace Inc (NPCE)
S Sale
2,093 -0.0%
7.60
US$15,907 		2,093 -0.0% 7.60 US$15,907
2024-10-03 2024-08-30
US Neuropace Inc (NPCE)
PrS Proposed sale
190,000
7.76
US$1,474,400 		190,000 7.76 US$1,474,400
2024-10-03 2024-08-30
US Neuropace Inc (NPCE)
S Sale
4,314 -0.1%
7.76
US$33,477 		4,314 -0.1% 7.76 US$33,477
2023-12-01 2023-12-01
US Neuropace Inc (NPCE)
S Sale
3,241 -0.1%
8.73
US$28,294 		3,241 -0.1% 8.73 US$28,294
2023-12-01 2023-11-30
US Neuropace Inc (NPCE)
S Sale
7,282 -0.1%
8.84
US$64,373 		7,282 -0.1% 8.84 US$64,373
2023-12-01 2023-11-29
US Neuropace Inc (NPCE)
S Sale
5,644 -0.1%
8.72
US$49,216 		5,644 -0.1% 8.72 US$49,216
2023-11-29 2023-11-28
US Neuropace Inc (NPCE)
S Sale
4,681 -0.1%
8.75
US$40,959 		4,681 -0.1% 8.75 US$40,959
2023-11-29 2023-11-27
US Neuropace Inc (NPCE)
PrS Proposed sale
262,836
8.74
US$2,297,187 		262,836 8.74 US$2,297,187
2023-11-29 2023-11-27
US Neuropace Inc (NPCE)
S Sale
6,490 -0.1%
8.96
US$58,150 		6,490 -0.1% 8.96 US$58,150